These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 635985)

  • 21. Immunosuppressive ALS. II. Antibody to Ia antigens in heterologous anti-lymphocyte serum.
    Zimmerman B; Tsui F; Delovitch T
    Immunology; 1979 May; 37(1):179-86. PubMed ID: 381173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absorption of normal lymphocytes on allogeneic spleen monolayers: depletion of alloreactivity is due to inhibition of CTL induction by released monolayer cells.
    Kelso A
    J Immunol; 1981 Oct; 127(4):1563-9. PubMed ID: 6456308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of genetic variation on the splenic T cell cytokine and specific serum antibody responses to Porphyromonas gingivalis in mice.
    Gemmell E; Winning TA; Grieco DA; Bird PS; Seymour GJ
    J Periodontol; 2000 Jul; 71(7):1130-8. PubMed ID: 10960020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Separation of anti-Ia (I-region associated antigens) from anti-H-2 antibodies in complex sera, by absorption on blood platelets. description of three new Ia specificities.
    Colombani J; Colombani M; Shreffler DC; David C
    Tissue Antigens; 1976 Feb; 7(2):74-85. PubMed ID: 58447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alloreactivity and tumor antigens: generation of syngeneic antilymphoma killer lymphocytes by alloimmunization of mice with normal cells.
    Sensi ML; Parenza M; Parmiani G
    J Natl Cancer Inst; 1983 Feb; 70(2):291-7. PubMed ID: 6571938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exclusive involvement of H-2Db or H-2Kd product in the interaction between T-killer lymphocytes and syngeneic H-2b or H-2d viral lymphomas.
    Gomard E; Duprez V; Reme T; Colombani MJ; Levy JP
    J Exp Med; 1977 Oct; 146(4):909-22. PubMed ID: 197198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macrophage MHC and T-cell receptors essential for rejection of allografted skin and lymphoma.
    Tashiro-Yamaji J; Maeda S; Ikawa M; Okabe M; Kubota T; Yoshida R
    Transplantation; 2013 Aug; 96(3):251-7. PubMed ID: 23836286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of H-2 and Ia antigens in graft-versus-host reactions (GVHR). Presence of host alloantigens on donor cells after GVHR and suppression of GVHR with an anti-Ia antiserum against hose Ia antigens.
    Prud'homme GJ; Sohn U; Delovitch TL
    J Exp Med; 1979 Jan; 149(1):137-49. PubMed ID: 33223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on the induction and expression of T cell-mediated immunity. IV. Non-overlapping populations of alloimmune cytotoxic lymphocytes with specificity for tumor-associated antigens and transplantation antigens.
    Kedar E; Bonavida B
    J Immunol; 1975 Nov; 115(5):1301-8. PubMed ID: 51889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancement of skin allograft survival by soluble alloantigen is serum-mediated.
    Rao VS; Bonavida B
    Transplantation; 1976 Jan; 21(1):42-50. PubMed ID: 1108325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Macrophage MHC receptor 2: a novel receptor on allograft (H-2D(d)K(d))-induced macrophage (H-2D(b)K(b)) recognizing an MHC class I molecule, H-2K(d), in mice.
    Tashiro-Yamaji J; Kubota T; Yoshida R
    Gene; 2006 Dec; 384():1-8. PubMed ID: 17010536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attempts to enhance kidney allografts in DLA-identical dogs with specific anti-IA-like sera.
    Soulillou JP; Keribin D; Lecoguic G; Robine-Leon S
    Transplantation; 1980 Apr; 29(4):314-9. PubMed ID: 6445102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specific tolerance induction of allo-K(b)-skin grafts by FK506 in the CD8-depleted H-2(k) recipients required low amounts of K(b)-antigen.
    Chen BG; Liu Z; Wu Y
    Transpl Immunol; 2005 Oct; 15(1):9-16. PubMed ID: 16223668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alloreactive cytotoxic anti-H-2 antibodies in sera of the syngeneically immunized C57BL/10ScSnPh, BALB/cJPh, and B10.A/SnPh mice.
    Capková J; Hasek M; Kousalová M; Holán V; Boubelík M
    Folia Biol (Praha); 1983; 29(2):200-8. PubMed ID: 6862049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inappropriate alloantigen-like specificities detected on reticulum cell sarcomas of SJL/J mice: characterization and biologic role.
    Bonavida B; Roman JM; Hutchinson IV
    Transplant Proc; 1980 Mar; 12(1):59-64. PubMed ID: 6154360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Organ donor or graft pretreatment to prolong allograft survival: lessons learned in the murine model.
    Pollak R; Blanchard JM
    Transplantation; 2000 Jun; 69(11):2432-9. PubMed ID: 10868654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transplantation behavior of allotransplantable tumor lines derived from immunologically modified hosts.
    Parks RC; Jacobs BB
    J Natl Cancer Inst; 1975 May; 54(5):1079-83. PubMed ID: 236395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allogeneic versus semiallogeneic F1 bone marrow transplantation into sublethally irradiated MHC-disparate hosts. Effects on mixed lymphoid chimerism, skin graft tolerance, host survival, and alloreactivity.
    Pierce GE
    Transplantation; 1990 Jan; 49(1):138-44. PubMed ID: 2137269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of alien H-2 specificities of a chemically induced BALB/c fibrosarcoma.
    Meschini A; Invernizzi G; Parmiami G
    Int J Cancer; 1977 Aug; 20(2):271-83. PubMed ID: 70414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ir-associated murine alloantigens: demonstration of multiple Ia specificities in H-2 alloantisera after selective absorptions.
    Sachs DH; Cone JL
    J Immunol; 1975 Jan; 114(1 Pt 1):165-9. PubMed ID: 122984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.